In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis

Clinical and Vaccine Immunology

Volumn 16, Issue 1, 2009, Pages 111-115

  Priya, V Hari Sai ^a   Anuradha, B ^a,b   Gaddam, Suman Latha ^a   Hasnain, Seyed E ^c   Murthy, K J R ^a   Valluri, Vijaya Lakshmi ^a,b  

^a Bhagwan Mahavir Medical Research Centre   (India)

^b LEPRA Society   (India)

^c UNIVERSITY OF HYDERABAD   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 10; INTERLEUKIN 12; MYCOBACTERIUM ANTIGEN; MYCOBACTERIUM BOVIS BCG RECOMBINANT 32 KDA ANTIGEN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOLOGICAL MONITORING; MAJOR CLINICAL STUDY; MYCOBACTERIUM BOVIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TUBERCULOSIS;

ANTIGENS, BACTERIAL; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; MYCOBACTERIUM BOVIS; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 58149402010     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00243-08     Document Type: Article

References (35)

1. Anuradha, B., C. M. Santosh, V. Hari Sai Priya, G. Suman Latha, K. J. R. Murthy, and Valluri Vijaya Lakshmi. 2007. Age-related waning of in vitro interferon-γ levels against r32KDaBCG in BCG vaccinated children. J. Immune Based Ther. Vaccines 5:8. doi:10.1186/1476-8518-5-8.
2. Anuradha, B., S. S. Rakh, M. Ishaq, K. J. R. Murthy, and V. L. Valluri. 2008. Interferon-γ low producer genotype +874 overrepresented in bacillus Calmette-Guerin nonresponding children. Pediatr. Infect. Dis. J. 27:325-329.
3. Boesen, H., N. B. Jensen, T. Wilcke, and P. Andersen. 1995. Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect. Immun. 63:1491-1497.
4. Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677-686.
5. Fulton, S. A., J. M. Johnsen, S. F. Wolf, D. S. Sieburth, and W. H. Boom. 1996. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect. Immun. 64:2523-2531.
6. Fulton, S. A., J. V. Cross, Z. T. Toossi, and W. H. Boom. 1998. Regulation of interleukin-12 by interleukin-10, transforming growth factor-β, tumor necrosis factor-α and interferon-γ in human monocytes infected with Mycobacterium tuberculosis H37Ra. J. Infect. Dis. 178:1105-1114.
7. Havlir, D. V., R. S. Wallis, W. H. Boom, T. M. Daniel, K. Chervenak, and J. J. Ellner. 1991. Human immune response to Mycobacterium tuberculosis antigens. Infect. Immun. 59:665-670.
8. Hirsch, C. S., J. J. Ellner, R. Blinkhorn, and Z. Toossi. 1997. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc. Natl. Acad. Sci. USA 94:3926-3931.
9. Huygen, K., J. P. Van Vooren, M. Turneer, R. Bosmans, P. Dierckx, and J. De Bruyn. 1988. Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand. J. Immunol. 27:187-194.
10. Jo, E. K., H. J. Kim, D. Min, Y. Song, C. H. Song, T. H. Paik, J. W. Suhr, and J. K. Park. 2000. Dysregulated production of interferon-gamma, interleukin-4 and interleukin-6 in early tuberculosis patients in response to antigen 85B of Mycobacterium tuberculosis. Scand. J. Immunol. 51:209-217.
11. Kleinhenz, M. E., and J. J. Eliner. 1987. Antigen responsiveness during tuberculosis: regulatory interactions of T cell subpopulations and adherent cells. J. Lab. Clin. Med. 110:31-36.
12. McShane, H., A. A. Pathan, C. R. Sander, S. M. Keating, S. C. Gilbert, K. Huygen, H. A. Fletcher, and A. V. S. Hill. 2004. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat. Med. 10:1240-1244.
13. Mehra, V., J. Gong, D. V. Iyer, Y. Lin, C. T. Boylen, B. R. Bloom, and P. F. Barnes. 1996. Immune response to recombinant mycobacterial proteins in patients with tuberculosis. J. Infect. Dis. 174:431-434.
14. Moura, E. P., V. P. C. P. Toledo, M. H. P. Oliveira, S. Spíndola-de-Miranda, H. M. Andrade, and T. M. P. D. Guimarães. 2004. Pulmonary tuberculosis: evaluation of interferon-γ levels as an immunological healing marker based on the response to the bacillus Calmette-Guerin. Mem. Inst. Oswaldo Cruz 99:283-287.
15. Munk, E. M., J. De Bruyn, H. Gras, and S. H. Kaufmann. 1994. The Mycobacterium bovis 32-kilodalton protein antigen induces human cytotoxic T-cell responses. Infect. Immun. 62:726-728.
16. Nagai, S., H. G. Wiker, M. Harboe, and M. Kinomoto. 1991. Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect. Immun. 59:372-382.
17. Pai, M. 2005. Alternatives to the tuberculin skin test: interferon-γ assays in the diagnosis of Mycobacterium Tuberculosis infection. Indian J. Med. Microbiol. 23:151-158.
18. Raja, A. 2004. Immunology of tuberculosis. Indian J. Med. Res. 120:213-232.
19. Romangnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 7:227-257.
20. Rossi, G. A., B. Balbi, and F. Manca. 1987. Tuberculous pleural effusions. Evidence for selective presence of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection. Am. Rev. Respir. Dis. 136:575-579.
21. Sahiratmadja, E., B. Alisjahbana, T. de Boer, I. Adnan, A. Maya, H. Danusantoso, Ronald H. H. Nelwan, S. Marzuki, J. W. M. van der Meer, R. van Crevel, E. van de Vosse, and T. H. M. Ottenhoff. 2007. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect. Immun. 75:820-829.
22. Sepkowitz, K. A. 1995. AIDS, tuberculosis, and health care workers. Clin. Infect. Dis. 20:232-242.
23. Song, C.-H., H.-J. Kim, J.-K. Park, J.-H. Lim, U.-O. Kim, J.-S. Kim, T.-H. Paik, K.-J. Kim, J.-W. Suhr, and E.-K. Jo. 2000. Depressed interleukin-12 (IL-12), but not IL-18, production in response to a 30- or 32-kilodalton mycobacterial antigen in patients with active pulmonary tuberculosis. Infect. Immun. 68:4477-4484.
24. Surcel, M., M. T. Blomberg, and S. Paulie. 1994. Th1/Th2 profiles in tuberculosis based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 81:171-178.
25. Torres, M., T. Herrera, H. Villareal, E. A. Rich, and E. Sada. 1998. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect. Immun. 66: 176-180.
26. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008-4027.
27. Vijaya Lakshmi, V., Sunil Kumar, H. Surekha Rani, G. Suman Latha, and K. J. R. Murthy. 2005. Tuberculin specific T cell responses in BCG vaccinated children. Indian Pediatr. 42:36-40.
28. Vijaya, L. V., D. V. Rao, K. J. R. Murthy, and S. N. Jain. 1989. Study of the tuberculin test and its correlation with the in vitro responses. Lung India 2:63-66.
29. Vijaya, L. V., K. J. R. Murthy, D. V. Rao, and S. N. Jain. 1990. A study of the tuberculin test II: its correlation with the in vitro humoral responses. Lung India 2:69-71.
30. Walzl, G., K. Ronacher, J. F. Djoba Siawaya, and H. M. Dockrell. 2008. Biomarkers for TB treatment response: challenges and future strategies. J. Infect. 57:103-109.
31. Wiker, H. G., and M. Harboe. 1992. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol. Rev. 56:648-661.
32. Wiker, H. G., M. Harboe, S. Nagai, and J. Bennedsen. 1990. Quantitative and qualitative studies on the major extracellular antigen of M. tuberculosis H37Rv and Mycobacterium bovis BCG. Am. Rev. Respir. Dis. 141:830-838.
33. Wong, H. L., D. E. Wilson, J. C. Jenson, P. C. Familletti, D. L. Stremlo, and M. K. Gately. 1988. Characterization of a factor(s) which synergizes with recombinant interleukin 2 in promoting allogeneic human cytolytic T-lymphocyte responses in vitro. Cell. Immunol. 111:39-54.
34. Zhang, M., M. K. Gately, E. Wang, J. Gong, S. F. Wolf, S. Lu, R. L. Modlin, and P. F. Barnes. 1994. Interleukin 12 at the site of disease in tuberculosis. J. Clin. Investig. 93:1733-1739.
35. Zhang, M., J. Gong, D. H. Presky, W. Xue, and P. F. Barnes. 1999. Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis. J. Immunol. 162:2441-2447.